Australia markets open in 2 hours 1 minute

NovoCure Limited (NVCR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.78+0.59 (+4.16%)
At close: 04:00PM EDT
14.60 -0.18 (-1.22%)
After hours: 04:05PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.59B
Enterprise value 1.32B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.00
Price/book (mrq)4.43
Enterprise value/revenue 2.50
Enterprise value/EBITDA -8.29

Trading information

Stock price history

Beta (5Y monthly) 0.43
52-week change 3-79.55%
S&P500 52-week change 322.38%
52-week high 383.60
52-week low 310.87
50-day moving average 314.20
200-day moving average 317.13

Share statistics

Avg vol (3-month) 31.3M
Avg vol (10-day) 31.08M
Shares outstanding 5107.61M
Implied shares outstanding 6107.61M
Float 898.02M
% held by insiders 19.26%
% held by institutions 182.40%
Shares short (15 Apr 2024) 46.04M
Short ratio (15 Apr 2024) 43.46
Short % of float (15 Apr 2024) 46.71%
Short % of shares outstanding (15 Apr 2024) 45.61%
Shares short (prior month 15 Mar 2024) 45.54M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -36.67%
Operating margin (ttm)-28.51%

Management effectiveness

Return on assets (ttm)-11.18%
Return on equity (ttm)-48.70%

Income statement

Revenue (ttm)525.66M
Revenue per share (ttm)4.92
Quarterly revenue growth (yoy)13.40%
Gross profit (ttm)N/A
EBITDA -195.61M
Net income avi to common (ttm)-192.74M
Diluted EPS (ttm)-1.81
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)870.15M
Total cash per share (mrq)8.09
Total debt (mrq)595.26M
Total debt/equity (mrq)165.65%
Current ratio (mrq)6.26
Book value per share (mrq)3.34

Cash flow statement

Operating cash flow (ttm)-88.18M
Levered free cash flow (ttm)-28.4M